Libo Wang

5.1k total citations · 2 hit papers
124 papers, 3.2k citations indexed

About

Libo Wang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Libo Wang has authored 124 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 33 papers in Molecular Biology and 24 papers in Cancer Research. Recurrent topics in Libo Wang's work include Ferroptosis and cancer prognosis (20 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Respiratory viral infections research (12 papers). Libo Wang is often cited by papers focused on Ferroptosis and cancer prognosis (20 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Respiratory viral infections research (12 papers). Libo Wang collaborates with scholars based in China, United States and Switzerland. Libo Wang's co-authors include Xinwei Han, Chunguang Guo, Zaoqu Liu, Long Liu, Qin Dang, Taoyuan Lu, Siyuan Weng, Zaoqu Liu, Yuqing Ren and Yuyuan Zhang and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Libo Wang

113 papers receiving 3.2k citations

Hit Papers

Machine learning-based integration develops an immune-der... 2022 2026 2023 2024 2022 2023 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Libo Wang China 29 1.2k 770 536 512 418 124 3.2k
Ching‐Ping Tseng Taiwan 36 1.9k 1.6× 320 0.4× 487 0.9× 807 1.6× 374 0.9× 143 4.7k
Narong Khuntikeo Thailand 34 1.0k 0.8× 591 0.8× 781 1.5× 898 1.8× 198 0.5× 159 3.3k
Michelle Wong South Africa 23 1.4k 1.2× 383 0.5× 390 0.7× 440 0.9× 187 0.4× 47 3.3k
Kathleen C. Barnes United States 44 1.5k 1.3× 1.3k 1.7× 306 0.6× 243 0.5× 1.5k 3.5× 176 8.2k
Consolato Sergi Canada 36 2.0k 1.7× 530 0.7× 485 0.9× 710 1.4× 323 0.8× 336 5.4k
Ezra Burstein United States 39 2.5k 2.1× 279 0.4× 709 1.3× 820 1.6× 961 2.3× 88 4.9k
Min‐Jong Kang United States 26 1.6k 1.3× 1.1k 1.4× 222 0.4× 347 0.7× 1.1k 2.6× 66 3.7k
Yan Du China 30 1.0k 0.8× 302 0.4× 464 0.9× 524 1.0× 322 0.8× 155 2.9k
Florence Démenais France 40 1.3k 1.1× 1.0k 1.3× 208 0.4× 493 1.0× 1.3k 3.0× 165 5.9k
Hal Drakesmith United Kingdom 40 707 0.6× 337 0.4× 216 0.4× 196 0.4× 665 1.6× 93 5.6k

Countries citing papers authored by Libo Wang

Since Specialization
Citations

This map shows the geographic impact of Libo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Wang more than expected).

Fields of papers citing papers by Libo Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Wang. The network helps show where Libo Wang may publish in the future.

Co-authorship network of co-authors of Libo Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Libo Wang. A scholar is included among the top collaborators of Libo Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Libo Wang. Libo Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Lijuan, Cong Liu, Renjie Chen, et al.. (2024). Associations of ambient air pollution and daily outpatient visits for pediatric atopic dermatitis in Shanghai, China. Ecotoxicology and Environmental Safety. 286. 117231–117231. 3 indexed citations
2.
Zhao, Senfeng, Ruopeng Liang, Tingting Peng, et al.. (2024). METTL16 suppresses ferroptosis in cholangiocarcinoma by promoting ATF4 via m6A modification. International Journal of Biological Sciences. 21(1). 189–203. 2 indexed citations
3.
Xu, Yudi, Yuyuan Zhang, Yuhao Ba, et al.. (2024). Associations Between Cardiovascular Health (Life's Essential 8) and Mental Disorders. Clinical Cardiology. 47(9). e70019–e70019. 1 indexed citations
4.
Wang, Libo, et al.. (2024). Enhanced interactions within microenvironment accelerates dismal prognosis in HBV-related HCC after TACE. Hepatology Communications. 8(10). 1 indexed citations
5.
Su, Ling, Yonghao Gui, Quan Lu, et al.. (2023). Direct costs of community-acquired pneumonia for hospitalized children in Shanghai, China from 2018 to 2020: a cross-sectional analysis. Translational Pediatrics. 12(3). 308–319. 5 indexed citations
6.
Wang, Yanli, Yongming Wang, Ze Li, et al.. (2023). Seven undescribed compounds from the flower heads of Helianthus annuus L.. Phytochemistry. 211. 113712–113712. 1 indexed citations
7.
Liu, Zaoqu, Yuqing Ren, Chunguang Guo, et al.. (2023). Immunosenescence: molecular mechanisms and diseases. Signal Transduction and Targeted Therapy. 8(1). 200–200. 421 indexed citations breakdown →
9.
Ren, Yuqing, Chunguang Guo, Yuyuan Zhang, et al.. (2023). Associations Between Life's Essential 8 and Chronic Kidney Disease. Journal of the American Heart Association. 12(24). e030564–e030564. 35 indexed citations
10.
11.
Dang, Qin, Ziqi Sun, Yang Wang, et al.. (2022). Ferroptosis: a double-edged sword mediating immune tolerance of cancer. Cell Death and Disease. 13(11). 925–925. 95 indexed citations
12.
Liu, Zaoqu, Long Liu, Taoyuan Lu, et al.. (2021). Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management. Journal of Oncology. 2021. 1–20. 27 indexed citations
13.
Liu, Zaoqu, Libo Wang, Chunguang Guo, et al.. (2021). TTN/OBSCN ‘Double‐Hit’ predicts favourable prognosis, ‘immune‐hot’ subtype and potentially better immunotherapeutic efficacy in colorectal cancer. Journal of Cellular and Molecular Medicine. 25(7). 3239–3251. 45 indexed citations
14.
Liu, Zaoqu, Taoyuan Lu, Yanli Wang, et al.. (2021). Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer. Journal of Cellular and Molecular Medicine. 25(14). 6874–6886. 33 indexed citations
15.
Wang, Libo, Zaoqu Liu, Long Liu, et al.. (2021). CELF2 is a candidate prognostic and immunotherapy biomarker in triple‐negative breast cancer and lung squamous cell carcinoma: A pan‐cancer analysis. Journal of Cellular and Molecular Medicine. 25(15). 7559–7574. 14 indexed citations
16.
Wu, Xiao‐Lin, et al.. (2017). Changes of Expressions of Claudin-1,-2,-4 in Experimental Colitis Rats. Weichangbingxue. 599–603. 2 indexed citations
17.
Wu, Fangwei, et al.. (2014). [Serological survey of Toxoplasma gondii infection in some areas of Pu' er City].. PubMed. 26(5). 583–5. 1 indexed citations
18.
Jiang, Jinyong, et al.. (2012). Efficacy of different doses of albendazole and mebendazole against common soil-transmitted Helminths and Taenia spp.: a randomized controlled trial.. Journal of Pathogen Biology. 7(5). 360–366. 1 indexed citations
19.
Wang, Libo. (2003). Research and production on WG-600 micro-cultivator.
20.
Huang, Yang, et al.. (2002). A Survey on Risks of Malaria Infection among Different Populations in the Yuanjiang River Basin. 25(1). 26–29. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026